Controls (n=26) Non-GDM mothers (n=27) GDM mothers (n=27) Healthy neonates (n=27) IDM (n=27)
Total FAs 7054 ± 2231 9735 ± 2849*† 10182 ± 2427*† 3524 ± 722‡ 3996 ± 2000‡
C8 – C12 27.3 ± 10.3 45.2 ± 18.9* 38.5 ± 14.4* 43.1 ± 14.9‡ 42.4 ± 14.7‡
C13 – C18 6223 ± 1984 8589 ± 2642*† 9044 ± 2196*† 2791 ± 613‡ 3163 ± 1632‡
C20 – C22 794± 243 1100 ± 272*† 1106 ± 281*† 690 ± 136 791 ± 378
Values are expressed as means and standard deviations; parametric ANOVA with Dunnett T3 test for multiple comparisons; significant differences: * mothers vs. controls; † mothers vs. respective neonatal group; ‡ for neonates vs. controls; no difference either between the two groups of mothers or between the two groups of neonates was significant; NS: Not Significant; IDM: Infants of Diabetic Mothers; FAs: Fatty Acids; C8–C12: Medium-Chain FAs; C13–C18: Long-Chain FAs; C20–C22: Very Long-Chain FAs
Table 4: Serum levels (μmol/L) of fatty acids.